Victoria Socha

DocwireNews

Patients with chronic kidney disease face markedly increased risk for cardiovascular morbidity and mortality. Results of previous studies have suggested underutilization of invasive cardiovascular care for the treatment of acute coronary syndrome (ACS) in patients with CKD. Sanjana Kapoor, MD, and Steven Weisbord, MD, conducted a study comparing the use of invasive cardiovascular care for ACS and the association between use of invasive cardiovascular care for ACS with 5-year mortality in a contemporary cohort of patients with and without CKD. Intensive cardiovascular care was defined as coronary angiography (CA), percutaneous coronary intervention (PCI), or coronary artery bypass grafting (CABG).
Results of the study were reported during a poster session at NKF SCM22. The poster was titled Lower Utilization of Invasive Cardiac Care in Patients with Stage 3 and 4 Chronic Kidney Disease Admitted with Acute Coronary Syndrome in a Tertiary Healthcare System.
Patients hospitalized with ACS (ST-elevation myocardial infarction [STEMI] or NSTEMI) between January 1, 2016, and December 31, 2019, were included in the study. Patients with CKD stage 5 or end-stage kidney disease were excluded, as were patients with DNR orders or palliative care consults. International Classification of Diseases-Tenth Revision (ICD-10) primary discharge codes were used to identify ACS, and Current Procedural Terminology (CPT) and ICD-10-Procedure Coding System codes were used to  identify CA, PCI, and CABG procedures
Multivariable logistic regression was used to compare the use of invasive care based on CKD status. Cox hazard models were used to compare mortality
The study included 2316 NSTEMI patients and 478 STEMI patients. Of the total cohort, 540 patients had a diagnosis of CKD. Patients with CKD were more likely to be older (78 years of age vs 71 years of age; P&lt;.001), and to have type 2 diabetes mellitus (67% vs 42%; P&lt;.001), hypertension (98% vs 90%; P&lt;.001) and a history of stroke (35% vs 21%; P&lt;.001), compared with those without CKD.
Following adjustment for age, race, sex, and diagnosis of diabetes mellitus, hypertension, and history of stroke, patients with CKD were 32% less likely to undergo invasive cardiovascular procedures than those without CKD (adjusted odds ratio [aOR], 0.68; 95% confidence interval [CI], 0.54-0.87). The percentage of NSTEMI patients undergoing invasive cardiovascular procedures decreased with increasing CKD severity (83% vs 76% vs 68%; P&lt;.001). The aOR for invasive cardiovascular procedures in patients with CKD compared with patients without CKD was 0.61 (95% CI, 0.47-0.81).
In both the CKD group and the non-CKD group, there was improved survival with invasive cardiovascular procedures observed. The adjusted  hazard ratio for death at 5 years with performance of procedure was 0.63 (95% CI, 0.45-0.88) among CKD patients compared with 0.42 (95% CI, 0.33-0.53) in patients without CKD.
In summary, the authors said, “In a contemporaneous cohort of patients treated at a large, tertiary-referral hospital system, patients with CKD are less likely to undergo invasive care to treat ACS, despite a decrease in mortality with such treatment.”
Source: Kapoor S, Weisbord S. Lower utilization of invasive cardiac care in patients with stage 3 and 4 chronic kidney disease admitted with acute coronary syndrome in a tertiary healthcare system. Abstract of a poster (Poster #182) presented at the National Kidney Foundation 2022 Spring Clinical Meetings, Boston, Massachusetts, April 6-10, 2022.

Cecilia Brown

Team Develops Model to Enhance Prediction of KRAS Mutations in Patients With NSCLC

KRAS+ NSCLC

Amit Goyal, MD

DCB-BIF Trial Results Favor Use of Drug-Coated Balloons to Rescue Jeopardized Side-branches After Provisional Bifurcation Stenting

Interventional Cardiology

Rob Dillard

Novel Method for Predicting Immunotherapy Response in Melanoma Patients

Melanoma

Latest News

Invasive Cardiac Care for Patients with CKD

National Kidney Foundation 2022

Patients with chronic kidney disease face markedly increased risk for cardiovascular morbidity and mortality. Results of previous studies have suggested underutilization of ...

About Us

Editorial Policy

Advertising

eNewsletters

Contribute

Contact Us

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

Mesothelioma

Non-Small Cell Lung Cancer

Small Cell Lung Cancer

Squamous Cell Lung Carcinoma

Lung Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

The Oncology Brothers

Rheumatology Rounds With Dr. Maheswaranathan

Healthcare Unfiltered

The Fellow on Call

Partners

Hurricanes & Health Care

Career Center

Expert Interviews

Subscribe